News | October 24, 2012

Varian Medical Systems Receives Clearance to Market the Unique Radiotherapy System in China

Radiation Therapy Varian UNIQUE China

October 24, 2012 — Varian Medical Systems Inc., manufacturer of medical technology for treating cancer with radiotherapy, announced that China's State Food and Drug Administration (SFDA) has granted clearance to market the UNIQUE medical linear accelerator, a single-energy machine for treating cancer with advanced forms of image-guided radiotherapy. The versatile UNIQUE system can be used to deliver intensity-modulated radiotherapy (IMRT) and RapidArc treatments, which precisely target tumors while minimizing exposure of surrounding healthy tissues.

The UNIQUE radiotherapy system is the world's first low-energy (6MV) radiotherapy system that can be outfitted with high-tech image-guidance, beam shaping, and RapidArc technology for rapid treatment delivery. It also includes the latest release of Varian's market leading Eclipse treatment planning software, offering clinicians a seamless workflow for planning and delivering advanced radiotherapy treatments. It is a cost effective solution designed to make access to quality care more widely available to cancer patients around the world.

"Epidemiological data show that more than 2.2 million new cancer cases are diagnosed in China each year," said Tom Duffy, head of Varian's Oncology Systems business in Asia. "This presents the dedicated clinicians in China with daunting numbers of patients in need of treatment. Many departments operate two or three shifts to keep up with the demand for access to radiotherapy treatment. In recognition of the challenge, the Chinese Ministry of Health has announced a dramatic increase in the number of licenses available to hospitals for the purchase of additional accelerators. Varian created the UNIQUE system to help address the need for greater access to care in China and other parts of the world."

The UNIQUE system can be used to deliver RapidArc radiotherapy, an arc-based approach that makes it possible to complete an image-guided IMRT treatment in a matter of minutes — up to four times faster than is possible with conventional IMRT.

The UNIQUE system is ideally equipped for treating cancer of the head and neck, breast, cervix, lung, prostate and other tumors. It is available in two configurations: UNIQUE Performance Edition, which incorporates all the tools needed for image-guided RapidArc radiotherapy, and UNIQUE Power Edition, a more basic platform that can be upgraded at a later time. Either package is ideal for treatment centers looking to transition from older cobalt units to modern radiotherapy technology. The small footprint of the UNIQUE accelerator allows it to fit into most small, existing treatment vaults.

For more information:

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more